Natalie Raffoul featured in IAM 300 Global Leaders Guide

iam300 Global Leaders Natalie Raffoul image

Natalie Raffoul, managing partner at Brion Raffoul, has been selected as one of this year’s IAM Strategy 300 Global Leaders. The inaugural digital edition of the guide identifies the individuals who are leading the way in the development and implementation of strategies that maximize the value of IP portfolios. The guide draws from the worlds …

Read moreNatalie Raffoul featured in IAM 300 Global Leaders Guide

Natalie Raffoul Named in IAM Strategy 300: The World’s Leading IP Strategists

Natalie Raffoul, managing partner at Brion Raffoul, is profiled in the 2020 edition of the IAM Strategy 300. This global listing identifies “individuals who are leading the way in the development and implementation of strategies that maximise the value of intellectual property (IP) portfolios.”  Ms. Raffoul’s experience advising small and medium-sized enterprises through every step …

Read moreNatalie Raffoul Named in IAM Strategy 300: The World’s Leading IP Strategists

Brion Raffoul’s Patent Spotlight Part 1: Artificial Intelligence

By Tina Dekker, Art Brion, Dennis Haszko Welcome to Part 1 of Brion Raffoul’s Patent Spotlight! In this series, we will highlight new and interesting patents from various fields as inspiration to businesses and innovators. A patent’s value to a business is not always evident and can be often misunderstood. By sharing recent patent stories …

Read moreBrion Raffoul’s Patent Spotlight Part 1: Artificial Intelligence

COVID-19 Crisis: Canadian Government amends Patent Act to produce patented medical supplies

By Liz Gray and Natalie Raffoul Last week, the Government of Canada passed an omnibus bill in response to the COVID-19 crisis that adds special powers to the Patent Act to ensure medical supplies, medication or vaccines can be produced locally. Under the new Section 19.4(1), upon application of the Minister of Health, the Commissioner …

Read moreCOVID-19 Crisis: Canadian Government amends Patent Act to produce patented medical supplies

Offering for sale could be a public disclosure of your invention: get patent pending before selling!

Generating income is typically top of mind for any business. For technology companies, this often means that sales and marketing go hand-in-hand with product development. During product development, confidential clauses in agreements shield companies from public disclosure of the invention. However, the United States has an “on-sale” bar which prevents one from patenting an invention …

Read moreOffering for sale could be a public disclosure of your invention: get patent pending before selling!

File Wrapper Estoppel in Canada – How Far Are the Courts Willing to Go?

Since the coming-into-force date of new section 53.1 of the Patent Act in December 2018, Canadian practitioners have been waiting to see how broad this “file wrapper estoppel” provision will be interpreted. Recently, the Federal Court released a decision that expands the scope of s. 53.1 to potentially include foreign prosecution file wrappers. However, this …

Read moreFile Wrapper Estoppel in Canada – How Far Are the Courts Willing to Go?